Clinical Trial Update: The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Public Speaking Environment [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating quetiapine (Seroquel) for social anxiety disorder in a public speaking setting has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: University of Minnesota | Conditions: Social Phobia | Phase 4 | Status: COMPLETED